Amedeo's Top 20

Amedeo Smart

Independent Medical Education


08 June 2015

Multidisciplinary Journal Club

  1. Sharma M, Cornelius VR, Patel JP, Davies JG, et al.
    Efficacy and Harms of Direct Oral Anticoagulants in the Elderly for Stroke Prevention in Atrial Fibrillation and Secondary Prevention of Venous Thromboembolism: Systematic Review and Meta-Analysis.
    Circulation 2015.

  1. Riegger D, Hai R, Dornfeld D, Manz B, et al.
    The nucleoprotein of newly emerged H7N9 influenza A virus harbors a unique motif conferring resistance to antiviral human MxA.
    J Virol 2014.

  2. Chan RW , Kang SS, Yen HL, Li AC, et al.
    Tissue tropism of swine influenza viruses and reassortants in ex vivo cultures of the human respiratory tract and conjunctiva.
    J Virol 2011.

  3. Gilbert RE, Krum H.
    Heart failure in diabetes: effects of anti-hyperglycaemic drug therapy.
    Lancet 2015;385:2107-17.

  4. Agoti CN , Mwihuri AG, Sande CJ, Onyango CO, et al.
    Genetic relatedness of infecting and reinfecting respiratory syncytial virus strains identified in a birth cohort from rural Kenya.
    J Infect Dis 2012;206:1532-41.

  1. Shine B, McKnight RF, Leaver L, Geddes JR, et al.
    Long-term effects of lithium on renal, thyroid, and parathyroid function: a retrospective analysis of laboratory data.
    Lancet 2015.

  2. Woodruff PG, Agusti A, Roche N, Singh D, et al.
    Current concepts in targeting chronic obstructive pulmonary disease pharmacotherapy: making progress towards personalised management.
    Lancet 2015;385:1789-98.

  3. Li N, Ren A, Wang X, Fan X, et al.
    Influenza viral neuraminidase primes bacterial coinfection through TGF-beta-mediated expression of host cell receptors.
    Proc Natl Acad Sci U S A 2014.

  4. Massin S, Ventelou B, Nebout A, Verger P, et al.
    Cross-sectional survey: Risk-averse French general practitioners are more favorable toward influenza vaccination.
    Vaccine 2014.

  5. Blum KA.
    CD30: seeing is not always believing.
    Blood 2015;125:1358-9.

  1. Baillie GJ , Galiano M, Agapow PM, Myers R, et al.
    Evolutionary Dynamics of Local Pandemic H1N1/09 Influenza Lineages Revealed by Whole Genome Analysis.
    J Virol 2011.

  2. Knibbs LD , Morawska L, Bell SC.
    The risk of airborne influenza transmission in passenger cars.
    Epidemiol Infect 2011.

  3. Brundage M, Sydes MR, Parulekar WR, Warde P, et al.
    Impact of Radiotherapy When Added to Androgen-Deprivation Therapy for Locally Advanced Prostate Cancer: Long-Term Quality-of-Life Outcomes From the NCIC CTG PR3/MRC PR07 Randomized Trial.
    J Clin Oncol 2015.

  4. Mazieres J, Zalcman G, Crino L, Biondani P, et al.
    Crizotinib therapy for advanced lung adenocarcinoma and a ROS1 rearrangement: results from the EUROS1 cohort.
    J Clin Oncol 2015;33:992-9.

  5. Tshefu A, Lokangaka A, Ngaima S, Engmann C, et al.
    Oral amoxicillin compared with injectable procaine benzylpenicillin plus gentamicin for treatment of neonates and young infants with fast breathing when referral is not possible: a randomised, open-label, equivalence trial.
    Lancet 2015.

  1. Jacobsen ED, Sharman JP, Oki Y, Advani RH, et al.
    Brentuximab vedotin demonstrates objective responses in a phase 2 study of relapsed/refractory DLBCL with variable CD30 expression.
    Blood 2015;125:1394-402.

  2. Bayne CE, Williams SB, Cooperberg MR, Gleave ME, et al.
    Treatment of the Primary Tumor in Metastatic Prostate Cancer: Current Concepts and Future Perspectives.
    Eur Urol 2015.

  3. Morita M, Joyce D, Miller C, Fung JJ, et al.
    Rejection triggers liver transplant tolerance: Involvements of mesenchyme-mediated Immune Control Mechanisms.
    Hepatology 2015.

  4. Danese S, Rudzinski J, Brandt W, Dupas JL, et al.
    Tralokinumab for moderate-to-severe UC: a randomised, double-blind, placebo-controlled, phase IIa study.
    Gut 2015;64:243-9.

  5. Zhang B, Cohen JE, Bondy SJ, Selby P, et al.
    Duration of nicotine replacement therapy use and smoking cessation: a population-based longitudinal study.
    Am J Epidemiol 2015;181:513-20.


more..


Privacy Policy